Hata Yujiro S
President and CEO
Hata Yujiro S has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 8, 2026.
On the most recent filing, Hata Yujiro S is listed as President and CEO at IDEAYA Biosciences, Inc. Inside the rolling window, Hata Yujiro S reported no open-market purchases and 1 open-market sale totaling $985K in IDYA.
Companies traded
Other insiders at IDYA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$985K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hata Yujiro S made?
Hata Yujiro S has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Hata Yujiro S trade?
Hata Yujiro S has filed SEC Form 4 disclosures for 1 company, including IDYA.
When was Hata Yujiro S's most recent SEC Form 4 filing?
Hata Yujiro S's most recent SEC Form 4 filing on Tracefour is dated Oct 8, 2026.
What is Hata Yujiro S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hata Yujiro S is listed as President and CEO.
What is Hata Yujiro S's total buy and sell value in the current window?
Inside the rolling retention window, Hata Yujiro S bought $0 and sold $985K based on SEC Form 4 filings.
What was Hata Yujiro S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 26,338 IDYA shares on 2026-10-06, worth $985K, per SEC Form 4 filings.